News - United Therapeutics


Current filters:

United Therapeutics

Popular Filters

United Therapeutics subpoenaed over drug marketing practices


US drugmaker United Therapeutics says it has received a subpoena from the Office of the Inspector General…

AdcircaLegalMarkets & MarketingNorth AmericaPharmaceuticalRemodulinTyvasoUnited Therapeutics

United Therapeutics sues Sandoz over Remodulin patent infringement


United Therapeutics (Nasdaq: UTHR) says that it has filed a law suit in the US District Court for the…

Cardio-vascularGenericsLegalNorth AmericaNovartisPatentsPharmaceuticalRemodulinSandozUnited Therapeutics

Sandoz challenges United Thera’s Remodulin patents


US drugmaker United Therapeutics (Nasdaq: UTHR) says that it has received a Paragraph IV Certification…

GenericsNorth AmericaNovartisPatentsPharmaceuticalRegulationRemodulinRespiratory and PulmonarySandozUnited Therapeutics

United Thera’s oral PAH drug treprostinil fails in Ph III study


US biotech firm United Therapeutics (Nasdaq: UTHR) says that preliminary results from its FREEDOM-C(2)…

BiotechnologyRegulationResearchRespiratory and PulmonaryTreprostinilUnited Therapeutics

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top